rs376230356
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000784.4(CYP27A1):c.380G>A(p.Arg127Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,614,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R127W) has been classified as Pathogenic.
Frequency
Consequence
NM_000784.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP27A1 | NM_000784.4 | c.380G>A | p.Arg127Gln | missense_variant | 2/9 | ENST00000258415.9 | NP_000775.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP27A1 | ENST00000258415.9 | c.380G>A | p.Arg127Gln | missense_variant | 2/9 | 1 | NM_000784.4 | ENSP00000258415 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152138Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251346Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135832
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461876Hom.: 0 Cov.: 32 AF XY: 0.0000179 AC XY: 13AN XY: 727236
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152138Hom.: 0 Cov.: 30 AF XY: 0.0000269 AC XY: 2AN XY: 74320
ClinVar
Submissions by phenotype
Cholestanol storage disease Pathogenic:6
Pathogenic, no assertion criteria provided | curation | GeneReviews | Aug 01, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jan 07, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 127 of the CYP27A1 protein (p.Arg127Gln). This variant is present in population databases (rs376230356, gnomAD 0.004%). This missense change has been observed in individual(s) with cerebrotendinous xanthomatosis (CTX) (PMID: 8730343, 10775536; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Arg94Gln. ClinVar contains an entry for this variant (Variation ID: 65866). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CYP27A1 protein function. This variant disrupts the p.Arg127 amino acid residue in CYP27A1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10430841, 10775536, 23659550, 27455001, 28623566). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | May 20, 2023 | The observed missense variant c.380G>A(p.Arg127Gln) in CYP27A1 gene has been reported previously in homozygous state in individuals with Cerebrotendinous xanthomatosis (Ragno M, et al., 2015, Kapás I, et al., 2014). The other variants that disrupt this residue have been determined to be Pathogenic (Chen C, et al., 2017).The c.380G>A variant has 0.002% allele frequency in gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic/Likely Pathogenic.The amino acid Arginine at position 127 is changed to a Glutamine changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen, SIFT and MutationTaster) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg127Gln in CYP27A1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Mar 08, 2017 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 05, 2023 | PP1, PP4, PM2, PM3_strong, PM5 - |
CYP27A1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 29, 2024 | The CYP27A1 c.380G>A variant is predicted to result in the amino acid substitution p.Arg127Gln. Using legacy nomenclature, this variant is also known in the literature as p.Arg94Gln. This variant has been reported in the homozygous and compound heterozygous states in multiple patients with cerebrotendinous xanthomatosis (CTX) (Watts et al. 1996. PubMed ID: 8730343; Verrips et al. 2000. PubMed ID: 10775536; Ragno et al. 2015. PubMed ID: 26519892; Li et al. 2022. https://www.wjgnet.com/2307-8960/full/v10/i18/6168.htm). This variant is reported in 0.0040% of alleles in individuals of African descent in gnomAD and has been interpreted as pathogenic or likely pathogenic by multiple laboratories in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/65866). Of note, another variant impacting the same amino acid (p.Arg127Trp) has also been reported in patients with CTX (Verrips et al. 2000. PubMed ID: 10775536, Kapás et al. 2014. PubMed ID: 23659550; Chen et al. 2017. PubMed ID: 28623566). Based on this collective evidence, we interpret the c.380G>A (p.Arg127Gln) variant as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at